Aldeyra Therapeutics Inc. buy BiotechBee
Start price
01.10.23
/
70%
€6.42
Target price
30.11.25
€10.00
Performance (%)
-73.55%
End price
16.10.23
€1.70
Summary
This prediction ended on 16.10.23 with a price of €1.70. Massive losses of -73.55% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aldeyra Therapeutics Inc. | 11.155% | 11.155% | -2.398% |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% |
According to BiotechBee what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0